Relit Bio · Precision Oncology Support

Precision
Oncology’s
Missing Piece

Your access to molecular-based imaging and therapeutics - empowering precision oncology, led by worldwide experts.

Book a 30-minute conversation

How we help

Expert advisory support, working alongside your treating medical team.

The problem we’re solving

Cancer is complex. A single, focal snapshot can miss the bigger picture.

A biopsy samples one place at one moment. Conventional scans show anatomy, but may not reveal the molecular differences between tumors or explain why a treatment is working in one lesion and not another.

Biopsies are limited

One tissue sample may not represent every lesion. Tumors can differ across the body and change over time.

Size isn’t the full story

CT and MRI can track changes in tumor size, but may not show target expression or the biology behind resistance.

Location matters

Blood-based tests can provide molecular clues, but do not always show where active disease or resistant lesions are located.

Our solution

Image the unseen. Inform your next step.

Whole-body, biomarker-based imaging can help reveal where specific molecular targets are expressed. Relit’s experts review your records and molecular data to identify relevant radioligand imaging (RLI) and radioligand therapy (RLT) options to discuss with your care team.

Our advisory work can include an initial case review, expert discussion, a written recommendations summary, logistical guidance, and introductions to relevant investigators or clinical programs. Ongoing support can include repeat scan reviews and monitoring emerging options.

Imaging and therapy suitability, availability, and access depend on your clinical situation. Some options are investigational; no particular scan, treatment, access, or outcome is guaranteed.

People behind your support

Nuclear medicine expertise, brought to your care.

Our team brings experience in nuclear medicine, theranostics, radiochemistry, patient navigation, and precision oncology.

Leadership & patient support

Ryan Witt

Chief Executive Officer

Healthcare executive and patient advocate with experience across digital health, biopharmaceuticals, medical devices, and single-patient treatment access.

Madeleine Landry, PhD

Consulting Scientist

Experience developing monoclonal antibodies, peptides, lipid nanoparticles for mRNA delivery, and radioligand imagers and therapies, including work at LONZA and Stanford University.

Lotfi Abou-Elkacem, PhD

VP, Patient Navigation & Scientific Discovery

Biomedical scientist and precision oncology leader with experience at Stanford and MD Anderson. Focused on molecular imaging, theranostics, molecular profiling, and individualized patient strategies.

PrecisionOncology’sMissing Piece